Markers community sources associate with a working protocol: Sleep quality improved within the first 1-2 weeks IGF-1 increased 20-40%+ from baseline at 4-6 week bloodwork Gradual improvements in recovery, skin quality, or body composition by weeks 6-8 Mild, transient side effects (slight water retention, occasional joint stiffness) that resolve Patterns community sources describe before discontinuing: No sleep improvement after 2 weeks community sources describe verifying fasted injection timing and peptide source quality IGF-1 unchanged at 4-6 weeks community protocols describe increasing to twice-daily dosing (300 mcg AM + PM) or evaluating peptide authenticity Persistent water retention or joint pain beyond week 3 community sources interpret this as a dose running too high and describe reducing to 200 mcg Signals community and clinical sources associate with stopping: Persistent numbness or tingling in extremities (potential carpal tunnel from excessive GH) Blood glucose consistently elevated on follow-up labs Any signs of abnormal growth or tissue changes documented guidance is to discontinue and consult a physician For detailed protocol parameters, see the ipamorelin dosing guide
Is that correct
In my experience working with athletes and weekend warriors alike, ankle injuries receive far less respect than they deserve
However, there are some key differences: Short half-life: Most require multiple daily injections because their effects last only minutes to hours
It is recommended to take 2 tablets each day
Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Smith JD LL, et al
